Download presentation
Presentation is loading. Please wait.
Published byJan Brož Modified over 5 years ago
1
Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis
Brian B. Johnson, MD, Lisa A. Beck, MD, S. Shahzad Mustafa, MD JAAD Case Reports Volume 5, Issue 7, Pages (July 2019) DOI: /j.jdcr Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Therapeutic regimen from January 2018 to February 2019.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr ) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 AD before dupilumab.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr ) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
4
Fig 3 AD 72 hours after loading dose.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr ) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
5
Fig 4 AD 2 weeks after loading dose.
JAAD Case Reports 2019 5, DOI: ( /j.jdcr ) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.